PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-30.55%
Negative revenue growth while CVE stands at 0.00%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
1.96%
Gross profit growth of 1.96% while CVE is zero. Bruce Berkowitz would see if minimal improvements could expand further.
-9.82%
Negative EBIT growth while CVE is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-9.82%
Negative operating income growth while CVE is at 0.00%. Joel Greenblatt would press for urgent turnaround measures.
-10.68%
Negative net income growth while CVE stands at 0.00%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-10.86%
Negative EPS growth while CVE is at 0.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-10.86%
Negative diluted EPS growth while CVE is at 0.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.03%
Share change of 0.03% while CVE is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
0.15%
Diluted share change of 0.15% while CVE is zero. Bruce Berkowitz might see a minor difference that could widen over time.
-0.03%
Dividend reduction while CVE stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-10.38%
Negative OCF growth while CVE is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
54.43%
FCF growth of 54.43% while CVE is zero. Bruce Berkowitz would see if modest improvements in free cash can accelerate further.
650.59%
10Y CAGR of 650.59% while CVE is zero. Bruce Berkowitz would see if incremental growth can widen into a significant edge.
160.91%
5Y CAGR of 160.91% while CVE is zero. Bruce Berkowitz would see if small improvements can scale into a larger advantage.
29.84%
3Y CAGR of 29.84% while CVE is zero. Bruce Berkowitz would see if small gains can accelerate to a more decisive lead.
1708.47%
OCF/share CAGR of 1708.47% while CVE is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
102.79%
OCF/share CAGR of 102.79% while CVE is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
4.89%
3Y OCF/share CAGR of 4.89% while CVE is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
1159.25%
10Y net income/share CAGR of 1159.25% while CVE is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
435.30%
Net income/share CAGR of 435.30% while CVE is zero. Bruce Berkowitz would see if small mid-term gains can develop into a bigger lead.
-14.12%
Negative 3Y CAGR while CVE is 0.00%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
885.58%
Equity/share CAGR of 885.58% while CVE is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
231.59%
Equity/share CAGR of 231.59% while CVE is zero. Bruce Berkowitz might see a minor advantage that could compound if the firm maintains positive net worth growth.
85.42%
Equity/share CAGR of 85.42% while CVE is zero. Bruce Berkowitz sees if minor gains can snowball into a bigger lead soon.
1937.12%
Dividend/share CAGR of 1937.12% while CVE is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
952.41%
Dividend/share CAGR of 952.41% while CVE is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
516.82%
3Y dividend/share CAGR of 516.82% while CVE is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-10.85%
Firm’s AR is declining while CVE shows 0.00%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
3.08%
Inventory growth of 3.08% while CVE is zero. Bruce Berkowitz wonders if we anticipate a new wave of demand or risk being stuck with extra product.
0.72%
Asset growth of 0.72% while CVE is zero. Bruce Berkowitz checks if modest expansions can create a longer-term lead.
1.69%
BV/share growth of 1.69% while CVE is zero. Bruce Berkowitz sees if small growth can compound into a strong advantage.
-20.40%
We’re deleveraging while CVE stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
14.86%
SG&A growth of 14.86% while CVE is zero. Bruce Berkowitz sees more spend on admin or marketing, expecting stronger top-line in return.